Moreover, ACE2 has been identified as an AR-regulated target in certain types of cells in the lungs (24) and in prostate cancer cells, where both mRNA and protein expression of ACE2 were strongly upregulated by R1881 (25). This evidence concerns the gene ACE2 and prostate carcinoma.